Michael A. Horberg, MD, MAS

Associate Medical Director Research, Medical Education
Kaiser Permanente Mid-Atlantic States
Rockville, Maryland

Disclosure: Nothing to disclose

Presentation(s):

• LB9 - The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care

  Friday, October 4
  1:55 PM – 2:05 PM